FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011749225> ?p ?o ?g. }

• W3011749225 endingPage "e0230127" @default.
• W3011749225 startingPage "e0230127" @default.
• W3011749225 abstract "Overdose is a leading cause of death in the United States, especially among people who inject drugs (PWID). Improving naloxone access and carrying among PWID may offset recent increases in overdose mortality associated with the influx of synthetic opioids in the drug market. This study characterized prevalence and correlates of several naloxone outcomes among PWID.During 2018, a survey to assess experience with naloxone was administered to 915 participants in the AIDS Linked to the IntraVenous Experience (ALIVE) study, an ongoing community-based observational cohort of people who currently inject or formerly injected drugs in Baltimore, Maryland. We examined the associations of naloxone outcomes (training, supply, use, and regular possession) with socio-demographic, substance use and healthcare utilization factors among PWID in order to characterize gaps in naloxone implementation among this high-risk population.Median age was 56 years, 34% were female, 85% were African American, and 31% recently injected. In the past six months, 46% (n = 421) reported receiving training in overdose prevention, 38% (n = 346) had received a supply of naloxone, 9% (n = 85) had administered naloxone, and 9% (n = 82) reported usually carrying a supply of naloxone. Recent non-fatal overdose was not associated with any naloxone outcomes in adjusted analysis. Active opioid use (aOR = 2.10, 95% CI: 1.03, 4.28) and recent treatment of alcohol or substance use disorder (aOR = 2.01, 95% CI: 1.13, 3.56) were associated with regularly carrying naloxone.Further work is needed to encourage PWID to carry and effectively use naloxone to decrease rates of fatal opioid overdose. While accessing treatment for substance use disorder was positively associated with carrying naloxone, EMS response to 911 calls for overdose, the emergency department, and syringe services programs may be settings in which naloxone access and carrying could be encouraged among PWID." @default.
• W3011749225 created "2020-03-23" @default.
• W3011749225 creator A5003006739 @default.
• W3011749225 creator A5013317411 @default.
• W3011749225 creator A5019795531 @default.
• W3011749225 creator A5028879438 @default.
• W3011749225 creator A5029722797 @default.
• W3011749225 creator A5068280445 @default.
• W3011749225 date "2020-03-11" @default.
• W3011749225 modified "2023-10-16" @default.
• W3011749225 title "Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland" @default.
• W3011749225 cites W1966769583 @default.
• W3011749225 cites W1968086599 @default.
• W3011749225 cites W1980457357 @default.
• W3011749225 cites W1984650467 @default.
• W3011749225 cites W2011745000 @default.
• W3011749225 cites W2064047117 @default.
• W3011749225 cites W2072627207 @default.
• W3011749225 cites W2075709836 @default.
• W3011749225 cites W2101953252 @default.
• W3011749225 cites W2109334164 @default.
• W3011749225 cites W2139852527 @default.
• W3011749225 cites W2148275891 @default.
• W3011749225 cites W2269979437 @default.
• W3011749225 cites W2340412354 @default.
• W3011749225 cites W2395693294 @default.
• W3011749225 cites W2416976221 @default.
• W3011749225 cites W2530437112 @default.
• W3011749225 cites W2588063816 @default.
• W3011749225 cites W2604936718 @default.
• W3011749225 cites W2739252919 @default.
• W3011749225 cites W2740453671 @default.
• W3011749225 cites W2769114273 @default.
• W3011749225 cites W2771355338 @default.
• W3011749225 cites W2785424655 @default.
• W3011749225 cites W2792522767 @default.
• W3011749225 cites W2797333710 @default.
• W3011749225 cites W2803121508 @default.
• W3011749225 cites W2803607233 @default.
• W3011749225 cites W2885226220 @default.
• W3011749225 cites W2885248180 @default.
• W3011749225 cites W2903129964 @default.
• W3011749225 cites W2911642310 @default.
• W3011749225 cites W2944343780 @default.
• W3011749225 cites W2981311729 @default.
• W3011749225 cites W4200337926 @default.
• W3011749225 doi "https://doi.org/10.1371/journal.pone.0230127" @default.
• W3011749225 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7065783" @default.
• W3011749225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32160244" @default.
• W3011749225 hasPublicationYear "2020" @default.
• W3011749225 type Work @default.
• W3011749225 sameAs 3011749225 @default.
• W3011749225 citedByCount "20" @default.
• W3011749225 countsByYear W30117492252020 @default.
• W3011749225 countsByYear W30117492252021 @default.
• W3011749225 countsByYear W30117492252022 @default.
• W3011749225 countsByYear W30117492252023 @default.
• W3011749225 crossrefType "journal-article" @default.
• W3011749225 hasAuthorship W3011749225A5003006739 @default.
• W3011749225 hasAuthorship W3011749225A5013317411 @default.
• W3011749225 hasAuthorship W3011749225A5019795531 @default.
• W3011749225 hasAuthorship W3011749225A5028879438 @default.
• W3011749225 hasAuthorship W3011749225A5029722797 @default.
• W3011749225 hasAuthorship W3011749225A5068280445 @default.
• W3011749225 hasBestOaLocation W30117492251 @default.
• W3011749225 hasConcept C126322002 @default.
• W3011749225 hasConcept C170493617 @default.
• W3011749225 hasConcept C194828623 @default.
• W3011749225 hasConcept C201903717 @default.
• W3011749225 hasConcept C2776315796 @default.
• W3011749225 hasConcept C2778750930 @default.
• W3011749225 hasConcept C2779148768 @default.
• W3011749225 hasConcept C2781063702 @default.
• W3011749225 hasConcept C2908647359 @default.
• W3011749225 hasConcept C3017944768 @default.
• W3011749225 hasConcept C71924100 @default.
• W3011749225 hasConcept C72563966 @default.
• W3011749225 hasConcept C99454951 @default.
• W3011749225 hasConceptScore W3011749225C126322002 @default.
• W3011749225 hasConceptScore W3011749225C170493617 @default.
• W3011749225 hasConceptScore W3011749225C194828623 @default.
• W3011749225 hasConceptScore W3011749225C201903717 @default.
• W3011749225 hasConceptScore W3011749225C2776315796 @default.
• W3011749225 hasConceptScore W3011749225C2778750930 @default.
• W3011749225 hasConceptScore W3011749225C2779148768 @default.
• W3011749225 hasConceptScore W3011749225C2781063702 @default.
• W3011749225 hasConceptScore W3011749225C2908647359 @default.
• W3011749225 hasConceptScore W3011749225C3017944768 @default.
• W3011749225 hasConceptScore W3011749225C71924100 @default.
• W3011749225 hasConceptScore W3011749225C72563966 @default.
• W3011749225 hasConceptScore W3011749225C99454951 @default.
• W3011749225 hasFunder F4320332161 @default.
• W3011749225 hasFunder F4320337347 @default.
• W3011749225 hasFunder F4320337355 @default.
• W3011749225 hasIssue "3" @default.
• W3011749225 hasLocation W30117492251 @default.
• W3011749225 hasLocation W30117492252 @default.
• W3011749225 hasLocation W30117492253 @default.

• next